Today's Headlines in a Nutshell: 1. Researchers have discovered that bones seem to produce a hormone that regulates sugar and fat -- which is "a major determinant of the development of type 2 diabetes," according to a press release. 2. After all the Anti-Avandia coverage, latest stories on the popular diabetes drug have... Read more
In a 22-1 vote, a panel advising the FDA on the future of popular diabetes drug Avandia chose to keep the drug on the market. The panel review came after several studies that Avandia caused more risk for cardiovascular problems in patients taking the drug. Read more Avandia information here: Drug information.David Mendosa's Avandia... Read more
Both the presentations and the terms thrown around this large conference room are getting longer -- one sweeping glance around the room returns glossed-over faces and fidgeting. But the meeting presses on, its leaders hoping to reach some kind of conclusive finding about the risks of Avandia, GlaxoSmithKline's popular diabetes drug. The... Read more
GlaxoSmithKline representatives took center stage about an hour ago to defend Avandia (Rosiglitazone), the popular diabetes drug accused of causing increased incidence of cardiovascular problems in its patients. At 8:45 a.m., a low rustle skirted through the room as reporters reopened notebooks and prepared to write. After a lengthy... Read more